Search
for
Sort by
Research 61–90 of 1000+
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Under Development JAK Inhibitors for Dermatologic Diseases
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- New drugs under investigation for the treatment of alopecias
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Hair Follicle Reconstruction and Stem Cells
- Current and future pharmacotherapy for alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Alopecia Areata
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway